Table 1

ICER and cost-effectiveness thresholds in the settings considered in the cost-effectiveness model

ICER comparison per settingCost-effectiveness threshold/QALY gainedSource
UK£20 000 (EUR 23 862)*NICE†
£30 000 (EUR 35 793)*
DenmarkKr250 000 (EUR 33 624)‡National drug reimbursement committee
ColombiaCOP$52.4 million (EUR 15 975)§Colombian HTA guidance12
  • *Exchange rate used: 1 GBP=1.19 EUR.

  • †National Institute for Health and Care Excellence. Guide to the methods of technology appraisal, 2013.

  • ‡Exchange rate used: 1 DKK=0.13 EUR.

  • §Exchange rate used: COP$1=0.0003 EUR, equivalent to three times Colombian GDP.12

  • COP, Colombian peso; DKK, Danish kroner; EUR, Euro; GBP, British pound sterling; GDP, gross domestic product; HTA, health technology assessment; ICER, incremental cost-effectiveness ratio; Kr, Danish kroner; QALY, quality-adjusted life-year.